Vifor Pharma Group’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.
www.viforpharma.com AMOUNT: 33.000 Euros
Vifor Pharma supports the Gastro Update Europe 2020 as a Gold Partner.
Vifor Pharma supports the Gastro Update Europe 2020 as a Gold Partner.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
www.takeda.com AMOUNT: 10.000 Euros
Takeda supports the Gastro Update Europe 2020 as Partner.
Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships.
www.norgine.com This enables Norgine to acquire, develop and commercialise innovative products that make a real difference to the lives of patients around the world.
AMOUNT: 6.000 Euros
Norgine supports the Gastro Update Europe 2020 as Partner.
